Zkusit zdarma
Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc.

NVCT
Cena:
$ 10.35
-0.59 (-5.39%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

7:30 14-05-2026

Fort Lee, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or t...

Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade

Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade

10:55 07-05-2026

The average of price targets set by Wall Street analysts indicates a potential upside of 62.5% in Nu...

Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

7:30 05-05-2026

FORT LEE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or...

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights

7:30 11-02-2026

FORT LEE, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" o...

Nuvectis Pharma (NASDAQ:NVCT) Trading Up 5.8% – Should You Buy?

Nuvectis Pharma (NASDAQ:NVCT) Trading Up 5.8% – Should You Buy?

3:33 22-01-2026

Nuvectis Pharma, Inc. (NASDAQ: NVCT - Get Free Report) shot up 5.8% on Wednesday. The company traded...

Nuvectis Pharma (NASDAQ:NVCT) Stock Price Up 0.5% – Here’s Why

Nuvectis Pharma (NASDAQ:NVCT) Stock Price Up 0.5% – Here’s Why

2:08 27-12-2025

Nuvectis Pharma, Inc. (NASDAQ: NVCT - Get Free Report)'s stock price rose 0.5% on Friday. The compan...

CORRECTION: Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights

CORRECTION: Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights

8:15 04-11-2025

FORT LEE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Nov...

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

8:00 16-10-2025

Fort Lee, NJ, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical sta...

Nuvectis (NVCT) Q2 Loss Widens 43%

Nuvectis (NVCT) Q2 Loss Widens 43%

21:57 05-08-2025

Nuvectis (NVCT) Q2 Loss Widens 43%...

Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

7:30 05-08-2025

FORT LEE, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" o...

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

16:35 16-05-2025

Fort Lee, NJ, May 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or t...

Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?

Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?

11:00 09-05-2025

The average of price targets set by Wall Street analysts indicates a potential upside of 108.8% in N...

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

8:00 06-05-2025

FORT LEE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or...

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

8:00 14-03-2025

FORT LEE, NJ, March 14, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company...

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter's Over-Allotment Option

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter's Over-Allotment Option

8:30 07-02-2025

FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-sta...

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock

9:01 05-02-2025

FORT LEE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-s...

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

16:05 04-02-2025

FORT LEE, NJ, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-sta...

Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

10:56 25-11-2024

After losing some value lately, a hammer chart pattern has been formed for Nuvectis Pharma (NVCT), i...

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug

14:23 14-11-2024

Nuvectis Pharma, Inc. NVCT stock is trading lower after the company reported data from the Phase 1b ...

Nuvectis Pharma (NVCT) Is a Great Choice for 'Trend' Investors, Here's Why

Nuvectis Pharma (NVCT) Is a Great Choice for 'Trend' Investors, Here's Why

9:50 13-11-2024

Nuvectis Pharma (NVCT) could be a solid choice for shorter-term investors looking to capitalize on t...

close

NUVECTIS PHARMA, INC. REPORTS 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

11-02-2026
FORT LEE, N.J., FEB. 11, 2026 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" O...
Více zde

NUVECTIS PHARMA ANNOUNCES THE INITIATION OF THE PHASE 1B STUDY OF NXP900 IN COMBINATION WITH OSIMERTINIB IN PATIENTS WITH NSCLC

17-12-2025
THE STUDY IS DESIGNED TO EVALUATE THE SAFETY AND CLINICAL ACTIVITY OF NXP900 IN COMBINATION WITH OSI...
Více zde

NUVECTIS PHARMA TO HOST A VIRTUAL KEY OPINION LEADER MEETING TO DISCUSS THE NXP900 PHASE 1B PROGRAM IN ADVANCED SOLID TUMORS, INCLUDING THE COMBINATION WITH OSIMERTINIB IN NSCLC

25-11-2025
FORT LEE, NJ, NOV. 25, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT, THE “COMPANY...
Více zde

CORRECTION: NUVECTIS PHARMA, INC. REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

04-11-2025
FORT LEE, N.J., NOV. 04, 2025 (GLOBE NEWSWIRE) -- IN A RELEASE ISSUED UNDER THE SAME HEADLINE ON NOV...
Více zde

NUVECTIS PHARMA ANNOUNCES UPCOMING PRESENTATIONS FOR NXP900 AT THE 2025 AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

16-10-2025
FORT LEE, NJ, OCT. 16, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT), A CLINICAL STA...
Více zde

NUVECTIS PHARMA TO PARTICIPATE AT THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

04-09-2025
FORT LEE, NJ, SEPT. 04, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" OR...
Více zde

NUVECTIS PHARMA ANNOUNCES THE INITIATION OF THE PHASE 1B PROGRAM FOR NXP900

11-08-2025
THE PHASE 1B PROGRAM IS DESIGNED TO EVALUATE THE CLINICAL ACTIVITY OF NXP900 AS A SINGLE AGENT IN PA...
Více zde

NUVECTIS PHARMA, INC. REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

05-08-2025
FORT LEE, N.J., AUG. 05, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" O...
Více zde

NUVECTIS PHARMA PROVIDES FINAL CLINICAL DATA UPDATE FROM THE NXP800 PHASE 1B STUDY IN OVARIAN CANCER AND REPORTS COMPLETION OF THE NXP900 PHASE 1A DOSE ESCALATION STUDY

31-07-2025
AVAILABLE DATA FROM 13 PATIENTS WITH RECURRENT, PLATINUM RESISTANT, ARID1A-MUTATED OVARIAN CANCER TR...
Více zde

NUVECTIS PHARMA TO PRESENT AT THE H.C. WAINWRIGHT BIOCONNECT INVESTOR CONFERENCE

16-05-2025
FORT LEE, NJ, MAY 16, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" OR T...
Více zde

NUVECTIS PHARMA, INC. REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

06-05-2025
FORT LEE, N.J., MAY 06, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" OR...
Více zde

NUVECTIS PHARMA PROVIDES POSTER PRESENTATION HIGHLIGHTS FOR NXP900 FROM THE 2025 AACR MEETING

29-04-2025
PHASE 1A DOSE-ESCALATION STUDY DATA UPDATE: TREATMENT WITH NXP900 RESULTED IN EXPOSURE LEVELS LEADIN...
Více zde

NUVECTIS PHARMA TO PARTICIPATE IN THE 37TH ANNUAL ROTH CONFERENCE

14-03-2025
FORT LEE, NJ, MARCH 14, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (“NUVECTIS”, “COMPANY...
Více zde

MARKET NEWS ALERT: NUVECTIS PHARMA'S NXP900 DEMONSTRATES SUPERIOR EFFICACY IN NSCLC WHEN COMBINED WITH TAGRISSO IN CLEVELAND CLINIC STUDY, FOLLOWING NEW BUY RECOMMENDATION

05-03-2025
NEW YORK--(BUSINESS WIRE)---- $NVCT #CANCERSTOCKS--MARKET NEWS ALERTS REPORTS: NUVECTIS PHARMA (NASD...
Více zde

MARKET NEWS ALERT: NUVECTIS PHARMA RECEIVES $18 PRICE TARGET AND BUY RATING FROM LUCID CAPITAL MARKETS

27-02-2025
NEW YORK--(BUSINESS WIRE)---- $NVCT #PHARMA--MARKET NEWS ALERTS REPORTS: LUCID CAPITAL MARKETS HAS I...
Více zde

NUVECTIS PHARMA ANNOUNCES CLOSING OF $15.5 MILLION PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITER'S OVER-ALLOTMENT OPTION

07-02-2025
FORT LEE, NJ, FEB. 07, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT), A CLINICAL-STA...
Více zde

NUVECTIS PHARMA ANNOUNCES PRICING OF $13.5 MILLION PUBLIC OFFERING OF COMMON STOCK

05-02-2025
FORT LEE, N.J., FEB. 05, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT), A CLINICAL-S...
Více zde

NUVECTIS PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

04-02-2025
FORT LEE, NJ, FEB. 04, 2025 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT), A CLINICAL-STA...
Více zde

NUVECTIS PHARMA, INC. REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

05-11-2024
FORT LEE, N.J., NOV. 05, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" O...
Více zde

PESG RELEASES MARKET UPDATE: NUVECTIS PHARMA SHOWS PROMISING SYNERGY FOR NXP900 IN RECENT PRESENTATIONS; GROWING ANTICIPATION FOR UPCOMING NXP800 DATA UPDATE

28-10-2024
LONDON--(BUSINESS WIRE)---- $DRUG #NASDAQ--NUVECTIS PHARMA (NASDAQ: NVCT) IS GAINING MOMENTUM FOLLOW...
Více zde

NUVECTIS PHARMA ANNOUNCES ORPHAN DRUG DESIGNATION GRANTED BY THE FDA FOR NXP800 FOR THE TREATMENT OF ARID1A-DEFICIENT OVARIAN, FALLOPIAN TUBE, AND PRIMARY PERITONEAL CANCERS

29-08-2024
FORT LEE, N.J., AUG. 29, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) (“NUVECTIS...
Více zde

NUVECTIS PHARMA, INC. REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

06-08-2024
FORT LEE, N.J., AUG. 06, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" O...
Více zde

NUVECTIS PHARMA, INC. TO PRESENT AT THE H.C. WAINWRIGHT BIOCONNECT INVESTOR CONFERENCE

16-05-2024
FORT LEE, NJ, MAY 16, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" OR T...
Více zde

NUVECTIS PHARMA, INC. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

07-05-2024
FORT LEE, N.J., MAY 07, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" OR...
Více zde

NUVECTIS PHARMA'S NXP900 DEMONSTRATES ROBUST ACTIVITY IN NON-SMALL CELL LUNG CANCER CELL LINES

08-04-2024
HIGHLY SYNERGISTIC ANTIPROLIFERATIVE ACTIVITY IN EGFR-RESISTANT CELLS IN COMBINATION WITH OSIMERTINI...
Více zde

NUVECTIS PHARMA ANNOUNCES UPCOMING PRESENTATIONS AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH MEETING

19-03-2024
FORT LEE, NJ, MARCH 19, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" OR...
Více zde

NUVECTIS PHARMA TO PRESENT AT THE 36TH ANNUAL ROTH CONFERENCE

15-03-2024
FORT LEE, NJ, MARCH 15, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (“NUVECTIS”, “COMPANY...
Více zde

NUVECTIS PHARMA ANNOUNCES ENCOURAGING PRELIMINARY DATA FROM THE NXP800 PHASE 1B CLINICAL TRIAL IN PLATINUM-RESISTANT ARID1A-MUTATED OVARIAN CANCER

14-03-2024
33% RESPONSE RATE AND 100% DISEASE CONTROL RATE OBSERVED IN PATIENTS EVALUATED FOR EFFICACY COMPLETE...
Více zde

NUVECTIS PHARMA, INC. REPORTS FISCAL YEAR 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

05-03-2024
FORT LEE, N.J., MARCH 05, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" ...
Více zde

CORRECTION: NUVECTIS PHARMA ANNOUNCES PARTICIPATION AT UPCOMING INVESTOR CONFERENCES

09-02-2024
FORT LEE, NJ, FEB. 09, 2024 (GLOBE NEWSWIRE) -- NUVECTIS PHARMA, INC. (NASDAQ: NVCT) ("NUVECTIS" OR ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-11 00:00:008-KStáhnout
2026-02-11 00:00:0010-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-09-25 01:00:008-KStáhnout
2025-09-25 00:00:008-KStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-06-13 01:00:008-KStáhnout
2025-06-13 00:00:008-KStáhnout
2025-05-09 01:00:008-KStáhnout
2025-05-09 00:00:008-KStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 01:00:0010-QStáhnout
2025-05-06 00:00:008-KStáhnout
2025-05-06 00:00:0010-QStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-25 00:00:0010-KStáhnout
2025-02-24 23:00:008-KStáhnout
2025-02-24 23:00:0010-KStáhnout
2025-02-06 00:00:008-KStáhnout
2025-02-05 23:00:008-KStáhnout
2024-11-05 00:00:008-KStáhnout
2024-11-05 00:00:0010-QStáhnout
2024-11-04 23:00:008-KStáhnout
2024-11-04 23:00:0010-QStáhnout
2024-08-29 01:00:008-KStáhnout
2024-08-29 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-03-05 00:00:008-KStáhnout
2024-03-05 00:00:0010-KStáhnout
2024-03-04 23:00:008-KStáhnout
2024-03-04 23:00:0010-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-08 00:00:0010-QStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-07 23:00:0010-QStáhnout
2023-09-12 01:00:008-KStáhnout
2023-09-12 00:00:008-KStáhnout
2023-08-17 01:00:008-KStáhnout
2023-08-17 00:00:008-KStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-07-03 01:00:008-KStáhnout
2023-07-03 00:00:008-KStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-10 01:00:008-KStáhnout
2023-05-10 01:00:0010-QStáhnout
2023-05-10 00:00:008-KStáhnout
2023-05-10 00:00:0010-QStáhnout
2023-03-08 00:00:0010-KStáhnout
2023-03-07 23:00:0010-KStáhnout
2023-03-07 00:00:008-KStáhnout
2023-03-06 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-08-10 01:00:0010-QStáhnout
2022-08-10 00:00:0010-QStáhnout
2022-08-05 01:00:008-KStáhnout
2022-08-05 00:00:008-KStáhnout
2022-07-29 01:00:008-KStáhnout
2022-07-29 00:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-05-11 01:00:008-KStáhnout
2022-05-11 00:00:008-KStáhnout
2022-03-23 00:00:0010-KStáhnout
2022-03-22 23:00:0010-KStáhnout
2022-03-22 00:00:008-KStáhnout
2022-03-21 23:00:008-KStáhnout
2022-02-04 00:00:008-KStáhnout
2022-02-03 23:00:008-KStáhnout
preloader